Sally Hamry
Sally recently graduated with an MSc from the Department of Chemistry at McGill University where she used mass spectrometry to investigate natural product biosynthesis and protein conformational dynamics. As a science journalism intern at DDN, Sally has a passion for scientific storytelling and hopes to foster a greater understanding of science in multiple audiences. In her free time, you can find her making stained glass art, gardening, and exploring nature.
Articles by Sally Hamry
| 4 min read
A team of global scientists found an antibody-based therapeutic that they hope will stop the next rodent-borne hantavirus outbreak in its tracks.
| 3 min read
New inhibitors specific for gonorrhea enzymes may pave the way to treating multi-drug resistant infections.
| 3 min read
A bacterial inhibitor enhances conventional antibiotics by killing Staphylococcus aureus and stopping a communication system in Pseudomonas aeruginosa.
| 3 min read
Antibiotic resistance is on the rise and scientists are on the lookout for new therapeutics for treating human pathogens. One promising new venture repurposes antimalarial drugs to treat patients with chronic lung diseases such as cystic fibrosis.
Page 1 of 1 - 4 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Accelerating RNA therapeutic testing with liver microphysiological platforms
Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Shining light on the subcellular proteome
Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
